A culture medium supplement containing one or multiple antimicrobials that is intended to be used to suppress or inhibit the growth of native or resident microorganisms present in a clinical specimen to enhance recovery, isolation, and/or growth of pathogenic
| Company | Devices | Share |
|---|---|---|
| Oxoid Limited | 48 | 74% |
| Becton, Dickinson And Company | 10 | 15% |
| Clark Laboratories, Inc. | 5 | 8% |
| Remel, Inc. | 2 | 3% |
Company = labeler of record on GUDID. 4 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| JSK | Supplement, Culture Media | 46 |
| MDB | SYSTEM, BLOOD CULTURING | 9 |
| JSJ | Culture Media, Selective And Non-Differential | 5 |
| KIT | Media And Components, Synthetic Cell And Tissue Culture | 3 |
| MDB | System, blood culturing | 2 |
| MZC | System, detection, bacterial, for platelet transfusion produ | 2 |
Use these as the dimensions to specify in a tender line.
65 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Culture medium antimicrobial supplement IVD", from 4 companies. The largest labeler is Oxoid Limited with 74% of records.
JSK (Supplement, Culture Media), MDB (SYSTEM, BLOOD CULTURING), JSJ (Culture Media, Selective And Non-Differential), KIT (Media And Components, Synthetic Cell And Tissue Culture)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add culture medium antimicrobial supplement ivd to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.